A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of the trial is to determine the effect of a study drug known as LY2409021
on blood pressure and pulse rate in participants with type 2 diabetes mellitus (T2DM) when
compared to placebo. The study has two periods. Each participant will receive LY2409021 or
placebo in each period. At least 4 weeks will pass between periods. The study will last about
23 weeks for each participant. Participants may remain on stable dose metformin, as
prescribed by their personal physician.